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SUMMARY
In a study group of40 children who had been admitted to hospital with acute encephalitis, the disease
was due to infection with Japanese encephalitis virus (JEV). Three children developed recurrence of
disease 8-9 months later. No virus had been isolated from these three patients during the acute stage
of their illness, but virus was recovered from all during the recurrence phase by co-cultivation of their
peripheral blood mononuclear cells in primary mouse embryo fibroblast cultures. Virus was also
recovered by co-cultivation of peripheral blood mononuclear cells collected 8 months after their
acute disease from three out ofeight randomly selected asymptomatic children within the study group
but not from similar cultures set up from JEV-seronegative children used as controls. Virus was also
isolated by co-cultivation of T lymphocytes of asymptomatic children as detected by indirect
immunofluorescence or by inoculation in mice.
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INTRODUCTION
Japanese encephalitis (JE) is one of the major causes of acute
encephalitis with significant mortality throughout South-East
Asia (Umenai et al., 1985). The outcome of JE virus (JEV)
infection varies depending on the interaction of virus and the
host. Clinical encephalitis develops in only one out of the 600-
800 persons infected with JEV (Halstead, 1981). Experimental
studies carried out in mice showed JEV replication in several
organs after primary infection (Mathur et al., 1986a). The target
cells are macrophages and T lymphocytes (Mathur et al., 1989).
Primary infection in mice is followed by establishment of latent
infection ofT cells (Mathur, Kulshreshtha & Chaturvedi, 1989).
Since no information is available on latent infection in humans it
was thought important to investigate this phenomenon.
In mice JEV can be activated following immunosuppression
despite the presence of antibodies in vivo (Mathur et al., 1986a)
or after co-cultivation of latently infected cells in vitro (Mathur
et al., 1989). We have recently noticed recurrence of JEV-
induced disease in children. The persistence ofJEV-specific IgM
(Edelman et al., 1976) and sequelae after JEV infection in
humans have been well established (Schneider et al., 1974). We
defined latency in JEV as the condition in which no viral antigen
is detected in peripheral blood mononuclear cells (PBMC) by
immunofluorescence or by direct isolation techniques, but in
which the latently infected cells express virus after co-cultiva-
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tion. The recurrent disease was defined as the reappearance of
symptoms in a previously seropositive patient along with
increase in titre ofantibody or presence of specific IgM antibody
or virus isolation. Here we describe the latent and recurrent
disease as a consequence of activation of latent JEV in children.
MATERIALS AND METHODS
Lymphocyte separation
PBMC were isolated by Ficoll-Isopaque density gradient
(Nyegaard, Oslo, Norway) centrifugation. Briefly, the macro-
phages were obtained from PBMC by incubating 2 x 107 cells
for 2 h at 370C in glass Petri dishes with MEM-HEPES
containing 10% fetal calf serum (FCS) and antibiotics in the
presence of CO2 and collecting the glass-adherent cells. More
than 90% of these cells were phagocytic and were considered as
the monocyte/macrophage population. The non-adherent T
and B lymphocyte populations were purified by filtration
through a nylon-wool column by the technique of Julius,
Simpson & Herzenberg (1973) as described earlier (Mathur et
al., 1988). The purity was checked by treating these cells with
Leu 1 pan-T monoclonal antibody (Becton Dickinson, Heidel-
berg, Germany) or anti human IgG antisera as described
previously (Mathur et al., 1989). The purity of T lymphocyte
preparation was 89 + 2% and B lymphocyte purity was 97 + 1%.
Co-cultivation
Mouse embryo fibroblast cultures were prepared from 9-11 -
day-old pregnant mice negative for JEV antibodies. Peripheral
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blood mononuclear cells, or T and B lymphocyte, or monocyte/
macrophage-enriched subpopulations were co-cultivated on
mouse embryo fibroblast (MEF). Cells (2 x 106/ml) in MEM-
HEPES with 10% FCS were added to MEF (2 x 105 cells) and
incubated at 37 C. Several cultures were set up for each cell
subpopulation. The cultures were coded and examined on
alternate days for virus isolation by intracerebral inoculation in
mice or for JEV-specific antigen demonstration by indirect
immunofluorescence as described earlier (Mathur et al., 1990).
Throughout the study for indirect immunofluorescence, the
cultures were spotted in triplicate on teflon-coated slides and
were screened for virus antigen carefully. The anti-JEV mono-
clonal antibody designated 98.9.5i was kindly provided by Dr E.
A. Gould, Institute of Virology, Oxford, England, and was used
at a dilution of 1/100 of mouse ascitic fluid in PBS. It reacted
exclusively with JEV and did not react with any other flavivirus.
The smears were screened under a Dialux 20 Leitz fluorescent
microscope. The monoclonal antibody had been checked for
absence of non-specific reaction with normal mouse embryo
fibroblast cells.
Neutralization test
Neutralization tests were carried out in infant mice by titrating
the virus against immune sera of JE, West Nile (WN) and
dengue type 2 viruses as described previously (Mathur et al.,
1982). The immune sera were provided by the Director,
National Institute of Virology, Pune, India.
Serological study
The haemagglutination inhibition (HAI) antibodies were esti-
mated by the technique of Clarke & Casals (1958) using a
microtitre method as described earlier (Mathur, Arora &
Chaturvedi, 1983). Freeze-dried JEV antigen was kindly pro-
vided by the Director, National Institute of Virology, Pune.
Assay ofJgM
The IgM antibodies in blood were measured by an antibody
capture ELISA (Burke, Nisalak & Ussery, 1985). Hyperimmune
anti-JEV globulin conjugated to peroxidase was kindly pro-
vided by Dr B. L. Innis, Armed Forces Research Institute of
Medical Sciences, Thailand. The substrate solution contained
OPD (Sigma, St Louis, MO). Optical densities (OD) were
measured at 492 nm on a Titertek Multiskan reader. The sera
were tested in duplicate at a dilution of 1/10. The test serum OD/
negative control serum OD ratio (P/N) was calculated. Value of
P/N > 2 was considered positive.
Study group
Two-hundred and fifty-eight consecutive patients aged 6
months to 12 years admitted with acute encephalopathic illness
(acute, non-transient alteration of conciousness with or without
fever, or other neurological symptoms) from August 1987 to
December 1988 at G.M. & Associated Hospitals, Lucknow,
India, were studied. The diagnosis of JEV infection was
confirmed in 141 patients either by isolation and identification
of virus from CSF, or by detection of viral antigen in CSF cells
by indirect immunofluorescence using JEV monoclonal anti-
bodies or by the presence of virus-specific IgM in serum or four-
fold or greater rise in HAI antibody titre in serum. The case/
fatality ratio in JEV confirmed cases was 36%. Sequelae
following JEV infection were noticed in 27% of children (R.K.,
personal observation). Only those children were included in the
study who recovered and were seropositive for JEV. The study
group consisted of 40 asymptomatic children (aged 3-6 years)
whose parents agreed to participate in this follow-up study. Five
JEV non-immune children served as control.
The children were examined during acute stage (first 5 days
after onset of illness), during convalescence (between 5 and 15
days) and during latent stage (6 months later, when they were
free of virus or virus-specific IgM, and showed no rise in
antibody titres). The children were asked to return as soon as
any symptoms appeared. Three of the children developed mild
confusion to alteration of intellect, convulsion and loss of
memory within 8-9 months after infection. The severity of acute
illness in these subjects was not significantly different from that
of patients who recovered without recurrent symptoms. Eight
months after JEV illness, eight asymptomatic children were
randomly selected for the study. A proforma-directed history
was taken and physical and neurological examination was
performed on hospital admission and at every visit.
RESULTS
Follow-up study of asymptomatic children
Forty children with confirmed diagnosis of JEV infection, who
recovered completely, were included in this follow-up study. Six
months later none of these children had detectable virus,
whether PBMC were examined by indirect immunofluorescence
or inoculated into mice. The serum had no IgM and showed no
rise in antibody titres. Approximately 8 months after the
primary JEV infection, eight children were screened for the
presence of latent JEV. Table 1 shows the data of virus isolation,
antigen demonstration in CSF and antibody titres in blood
during acute and convalescent phase of infection in these
children (subjects 1-8). These children were screened for the
presence of latent JEV 8 months later by co-cultivation of
PBMC with MEF (Table 2).
Recovery ofJEVfrom PBMC of asymptomatic children
Peripheral blood mononuclear cells obtained from eight asymp-
tomatic children and five seronegative controls were co-culti-
vated on MEF cultures. The activated virus was detected by
indirect immunofluorescence using JEV-specific monoclonal
antibody or by virus isolation in mice. The results of immuno-
fluorescence were interpreted with great caution. In the PBMC
cultures of three out of eight asymptomatic children the JEV
antigen was detected. The infected cells showed a bright
cytoplasmic fluorescence and were clearly distinguished from
the uninfected or normal controls. A lag period of 10 days or
more (maximum 18 days) was observed before virus activation,
approximately 25-40'% of the cultures from each of the children
had latent virus. No virus was detected in PBMC of seronegative
controls (Table 2). The activation ofJEV in PBMC of the three
children (subjects no. 1, 4, 8) who had positive immunofluor-
escent cells was confirmed after isolation of virus in mice. The
neutralization tests were performed on all three isolates against
JEV, WN and Dengue antisera.
All strains were maximally neutralized by JEV immune sera.
Some cross-reactivity was also observed with WN and Dengue
sera (Table 3). A good correlation was observed in the results of
virus demonstration by immunofluorescence or by mice inocu-
lation.
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Table 1. Results of the diagnostic tests carried out at the acute phase of the
disease on children who were asymptomatic or developed recurrence ofJapanese
encephalitis virus (JEV) infection
Acute CSF JEV-Specific Serum HAI
IgMt antibody
Subject Age Virus
no. (years) Sex isolation IF* CSF Serumt Acute Con.
Asymptomatic cases
1 45 M - - + + 20 80
2 3 F - - + + 40 160
3 5 M - + + + 40 160
4 5 F - - + + 40 160
5 3-5 M - - + + 40 160
6 4 F - - + + 20 80
7 3 M - - + + 20 80
8 4 M - - + + 20 80
Recurrence of disease
9 6 M - - + + 40 160
10 5 F - + + + 20 80
1 1 4 M - - + + 40 160
* Virus identified as JEV in CSF cells by indirect immunofluorescence (IF)
using monoclonal antibodies. t IgM - P/N ratio > 2-0 in ELISA.
Table 2. Recovery of JEV from peripheral blood mononuclear cells of
children 8 or 9 months after the initial illness
JEV recovery
Earliest day of No. positive/no. tested
recovery after
Subject no. reactivation IF Mice
Asymptomatic
I 12 2/9 2/10
2 0 0/10 0/10
3 0 0/10 0/10
4 1 1 4/9 3/10
5 0 0/9 0/9
6 0 0/10 0/9
7 0 0/10 0/10
8 12 3/9 4/10
Recurrent disease
1 3 5/15 3/10
2 4 4/15 3/10
3 3 4/15 5/10
Controls (n=5) 0 0/40 0/35
Co-cultivation ofPBMC subpopulations with MEF
In order to delineate the cell subpopulation of PBMC respon-
sible for harbouring JEV, the enriched T and B lymphocyte and
macrophage subpopulation of latently infected asymptomatic
children were co-cultivated with MEF cells and screened on
alternate days for the virus activation by indirect immunofluor-
escence. The results summarized in Table 4 show the presence of
activated JEV in T lymphocyte of latently infected children
between days 10- 16 after co-cultivation. No virus was detected
Table 3. Results of neutralization test
Log neutralization index
Asymptomatic children Recurrent disease
(subject no.) (subject no.)
Reference
immune sera 1 4 8 9 10 11
Dengue-2 0-5 0-7 0-6 09 0-6 04
JEV 2-4 2-8 2-2 2-6 2-2 2-8
WN 0-9 0-8 09 1*1 10 12
Table 4. Recovery of JEV from enriched subpopulation of
PBMC of latently infected asymptomatic children
JEV
Earliest day of Recovered/no. tested
PBMC recovery after
Subpopulations* reactivation Asymptomatic Control
T lymphocytes 12 10/31 0/17
B lymphocytes 0 0/31 0/17
Macrophages 0 0/31 0/17
* Peripheral blood mononuclear cells enriched subpopula-
tion was obtained from three latently infected asymptomatic
children who had positive cultures (subjects no. 1, 4 and 8).
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Table 5. Serum antibody response in children at various times after JEV
infection
Antibody before virus
Antibody 6 months activation or after
post-infection recurrence of infection
Serum JEV HAI Serum JEV HAI
Subject no. IgM titres IgM titres
Asymptomatic
I 0 80 0 80
2 0 80 0 80
3 0 40 0 20
4 0 80 0 80
5 0 80 0 80
6 0 40 0 20
7 0 40 0 40
8 0 40 0 40
Recurrent disease
9 0 80 0 80A
320C
10 0 40 + 40A
80C
11 0 40 + 40A
160C
Controls (n=5) 0 10+0* 0 10+0*
A, acute serum; C, convalescent serum; serum JEV IgM-
ratio < 2 in MAC ELISA.
* All cases.
- (0)- P/N
in B lymphocytes or macrophages of these children or from any
enriched subpopulation of seronegative controls.
Study of children with recurrence of disease
Three of the 40 children with confirmed diagnosis of JEV
(subjects 9-11 in Table 1) were included in the follow-up study,
they developed recurrent symptoms after 8-9 months of
recovery. These patients complained of mild confusion convul-
sions and loss of memory. No virus was isolated from sera of
these patients by intracerebral inoculation in mice.
Cultivation of PBMC ofpatients with recurrence of disease on
MEF
PBMC obtained from the three patients with recurrence of
disease and from five control individuals were co-cultivated on
MEF cultures. The results summarized in Table 2 show that the
virus was activated from PBMC of all the three patients between
3 and 4 days of co-cultivation on fibroblasts. Of 15 cultures
made from each patient only four or five were positive. The
viruses isolated were identified as JEV by neutralization test in
infant mice using hyperimmune JEV, WN and Dengue viruses
sera (Table 3). No virus could be activated from JEV-seronega-
tive control individuals.
Antibody response
IgM to JEV was determined by MAC ELISA in sera collected
from patients during acute phase of illness from asymptomatic
children 8 months after primary infection and from three
children at the time of recurrent infection. The findings in Table
5 show that JEV IgM antibodies were present in all the acute
sera of encephalitis patients. Two out of three sera collected
from children who had recurrence of infection had IgM
antibodies. No IgM antibodies were seen in sera of the
asymptomatic and five normal children. The HAI findings in the
paired sera from encephalitis patients revealed significant
conversion of antibody titres with JEV. The antibody titres had
fallen by 8 months period. A rise in JEV-specific HAI antibody
titres was observed in the sera of the children who experienced
recurrence of infections.
DISCUSSION
The salient feature of the present study is the observation that
JEV established latent infection in peripheral blood mono-
nuclear cells of children who had JEV infection 8-9 months
previously. Some of these patients developed recurrence of
disease despite the presence of circulating antibodies. Activated
virus was isolated by co-cultivation from T lymphocytes of
PBMC of asymptomatic children on MEF cells, by indirect
immunofluorescence or by inoculation into the mice. The B
lymphocytes and macrophages of latently infected children did
not reactivate the virus.
JEV infection is one of the major causes of encephalitis
world over with high mortality (Umenai et al., 1985). Epidemics
ofJEV have been observed during October to December in post-
monsoon season in Northern India since 1978 (Mathur et al.,
1982), and our recent observations suggest that JEV is probably
endemic in this area (Kumar et al., 1988). Edelman et al. (1976)
reported persistence of the JEV-specific IgM antibody 116-135
days after acute illness and related it to acute virulence of JEV
infection. There are studies describing the sequelae following
JEV infection (Grossberg, Heyman & Keehn, 1962; Schneider et
al., 1974). To our knowledge, latency and recurrence of JEV
infection in human have not been shown before.
JEV is a neurotropic virus. In fatal cases localization of viral
antigen has been shown in the neurons (Johnson et al., 1985).
Attempts to isolate JEV in peripheral blood of acute JEV
patients have been unsuccessful (Mathur et al., 1982). We found
that a small percentage of T lymphocytes and macrophages are
infected in mice during acute infection (Mathur et al., 1988). In
the present study isolation of JEV from T lymphocytes of
latently infected children has been documented. Successful
activation of Epstein-Barr virus and HIV has been reported
from various leucocyte subpopulations or macrophage/mono-
cyte cells (Klein et al., 1976; Harper et al., 1986). Absence of
JEV-specific IgM in blood of asymptomatic children supports
the findings that virus has been truly latent in T lymphocytes.
Monoclonal antibody studies are underway to establish that the
JE serotypes recovered from patients' lymphocyte are identical
to strains isolated during the JEV epidemic in Utar Pradesh,
India, in 1978.
We have described the development of recurrence of symp-
toms due to latent JEV infections in three children. No virus was
isolated during the acute stage of illness, while lymphocyte co-
cultures were positive at the time of recurrence in these children.
Patients with recurrence of JEV infection develop diminished
lymphoproliferative response (manuscript in preparation). Cur-
rently the role of host responses in reappearance of disease in
latent JEV infection is not clear. A study is underway to find out
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the role of infection with other infectious agents with regard to
activation of JEV infection. The phenomenon of latency and
reactivation of virus continues to be a perplexing and challeng-
ing problem as its mechanism remains obscure. In mouse
experiments the immunosuppression by cyclophosphamide or
during pregnancy after latency resulted in the reappearance of
JEV (Mathur et al., 1986a) with the generation of quick, short-
lived secondary immune response (Mathur, Kulshreshtha &
Chaturvedi, 1987). The latently infected mice elicited dimin-
ished cell-mediated immune response as compared to control
(Mathur et al., 1989) and similar effects of JEV infection have
been observed in asymptomatic, congenitally infected baby mice
(Mathur et al., 1986b). Some of the JEV-infected mice showed
runting or developed hydrocephalus or died (unpublished data).
Production of low molecular weight inhibitory factor by HSV-
stimulated PBL has been shown (Sheridan et al., 1987). This
might help the virus to replicate sufficiently to cause clinical
symptoms. The observations described here were made in only a
few patients, and the results, therefore, require confirmation in
larger series of patients.
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